29Mar

Idris Oncology one of first companies to receive free human tissue through Codex4SME’s

CURAM3

The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application. Interreg project Codex4SME's supports entrepreneurs in Life Sciences & Health sector in obtaining human tissue from biobanks. The application process for tissue can be very lingering and complicated.

The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application.

Read our story on the transition to personalized medicine here! (in Dutch)

“It is always hard for SME’s to obtain human samples of any kind,” says Idris CEO and founder Hans Peter Mulder. “That’s why we are so happy with the support from Codex4SME’s and its regional partner InnovationQuarter. What has really speeded Idris’ product development is the fact that Codex4SME’s also covers the costs and assists with the supply form BioBank Graz. This way we can treat cancer better.”

“I’m very happy that Idris was one of the first to obtain these free samples* as it will help making cancer treatment to become more personalized,” says Stéfan Ellenbroek, senior business developer Life Sciences and Health at InnovationQuarter. “There are currently a couple of other Zuid-Holland companies in discussion with the BioBank Graz for prospective tissue collection, but I also urge the rest of the ecosystem to check out this nice chance as the vouchers for free samples are limited in amount. Any companies with questions can contact me!”

Related

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and c...

Read More >

Novodiag® launch, a new diagnostic solution for infectious diseases.

Espoo, Finland, January 3rd, 2018 - Mobidiag, a Finnish molecular diagnostics company, launches Novo...

Read More >

OGT makes market-leading NGS coverage and expertise more accessible

Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expand...

Read More >

Isohelix Double Registers its DNA Saliva and Buccal Cell Collectors with the Chinese CFDA.

Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors ar...

Read More >

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. (Eastleigh, UK) is deli...

Read More >